CIK 0002010788 · <br>Emerging growth company
EXOZYMES INC.
Sign in to watch- Ticker
- EXOZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 834550057
- Phone
- (626) - 415 - 1488
- Business address
- 750 ROYAL OAKS DR, MONROVIA, CA, 91016
- Former names
- Invizyne Technologies Inc
- Open-market buys, last 90 days
- $6,405
- in 1 filing
- Open-market sales, last 90 days
- $19,427
- in 1 filing
Net −$13,021. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-26 | Heltzen Michael Chief Executive Officer | Purchase | +4 | $7.58 | $30 | 14,708 |
| 2026-08-26 | Heltzen Michael Chief Executive Officer | Purchase | +251 | $7.35 | $2K | 14,704 |
| 2026-08-26 | Heltzen Michael Chief Executive Officer | Purchase | +250 | $7.60 | $2K | 14,453 |
| 2026-08-25 | Heltzen Michael Chief Executive Officer | Purchase | +250 | $7.52 | $2K | 14,203 |
| 2026-08-25 | Heltzen Michael Chief Executive Officer | Purchase | +100 | $7.50 | $750 | 13,953 |
| 2025-07-02 | Heltzen Michael Chief Executive Officer | Purchase | +1,040 | $10.22 | $11K | 10,628.8 |
| 2025-01-17 | Heltzen Michael Chief Executive Officer | Purchase | +1,767 | $10.78 | $19K | 3,872 |
| 2025-01-16 | Heltzen Michael Chief Executive Officer | Purchase | +121 | $10.72 | $1K | 2,105 |
| 2024-11-15 | Heltzen Michael Chief Executive Officer | Purchase | +1,984 | $11.10 | $22K | 1,984 |
Page 1 of 1 · 9 trades